Free Trial

National Vision (EYE) Competitors

National Vision logo
$10.80 +0.05 (+0.47%)
As of 01/17/2025 04:00 PM Eastern

EYE vs. NVST, IRTC, NVCR, LIVN, WRBY, ENOV, TNDM, TMDX, CNMD, and LMAT

Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), iRhythm Technologies (IRTC), NovoCure (NVCR), LivaNova (LIVN), Warby Parker (WRBY), Enovis (ENOV), Tandem Diabetes Care (TNDM), TransMedics Group (TMDX), CONMED (CNMD), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.

National Vision vs.

National Vision (NASDAQ:EYE) and Envista (NYSE:NVST) are both consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment.

In the previous week, National Vision had 7 more articles in the media than Envista. MarketBeat recorded 11 mentions for National Vision and 4 mentions for Envista. Envista's average media sentiment score of 0.46 beat National Vision's score of 0.24 indicating that Envista is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
0 Very Positive mention(s)
6 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Envista
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

National Vision has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Envista has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500.

National Vision received 220 more outperform votes than Envista when rated by MarketBeat users. Likewise, 65.46% of users gave National Vision an outperform vote while only 37.78% of users gave Envista an outperform vote.

CompanyUnderperformOutperform
National VisionOutperform Votes
254
65.46%
Underperform Votes
134
34.54%
EnvistaOutperform Votes
34
37.78%
Underperform Votes
56
62.22%

National Vision has higher earnings, but lower revenue than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$2.13B0.40-$65.90M-$0.20-54.00
Envista$2.50B1.36-$100.20M-$7.77-2.55

National Vision currently has a consensus price target of $13.50, indicating a potential upside of 25.00%. Envista has a consensus price target of $20.21, indicating a potential upside of 1.92%. Given National Vision's stronger consensus rating and higher probable upside, equities research analysts clearly believe National Vision is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
Envista
2 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.07

National Vision has a net margin of -0.81% compared to Envista's net margin of -53.42%. Envista's return on equity of 3.76% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision-0.81% 3.52% 1.39%
Envista -53.42%3.76%2.24%

Summary

National Vision beats Envista on 9 of the 16 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionOphthalmic goods IndustryStaples SectorNASDAQ Exchange
Market Cap$850.50M$11.01B$15.24B$9.06B
Dividend YieldN/A1.63%2.91%4.02%
P/E Ratio-54.0039.7321.3517.34
Price / Sales0.405.213.91134.53
Price / Cash5.9815.7316.8035.97
Price / Book1.023.175.984.80
Net Income-$65.90M$235.23M$600.74M$224.91M
7 Day Performance2.66%-0.65%1.74%1.90%
1 Month Performance-4.00%-2.77%1.75%5.08%
1 Year Performance-44.93%-2.79%6.80%21.15%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
2.612 of 5 stars
$10.80
+0.5%
$13.50
+25.0%
-44.9%$850.50M$2.13B-54.0013,998Short Interest ↑
News Coverage
Gap Up
NVST
Envista
3.4974 of 5 stars
$19.12
+2.9%
$20.21
+5.7%
-14.0%$3.29B$2.50B-2.4612,700News Coverage
IRTC
iRhythm Technologies
1.4425 of 5 stars
$94.81
-3.0%
$108.45
+14.4%
-2.0%$2.97B$560.03M-19.511,790
NVCR
NovoCure
3.1156 of 5 stars
$26.67
-2.8%
$32.67
+22.5%
+110.7%$2.89B$577.74M-19.051,320Analyst Forecast
Analyst Revision
News Coverage
LIVN
LivaNova
3.5627 of 5 stars
$47.46
+1.7%
$69.17
+45.7%
-4.2%$2.58B$1.15B113.002,900Analyst Upgrade
WRBY
Warby Parker
2.3033 of 5 stars
$24.97
-1.4%
$20.73
-17.0%
+89.3%$2.54B$742.53M-92.483,491Analyst Forecast
Short Interest ↓
News Coverage
ENOV
Enovis
3.0524 of 5 stars
$45.34
+1.3%
$67.00
+47.8%
-18.9%$2.53B$2.00B-20.706,550Short Interest ↑
News Coverage
TNDM
Tandem Diabetes Care
4.5431 of 5 stars
$35.65
-1.0%
$53.81
+50.9%
+45.8%$2.34B$854.35M-18.472,400Positive News
TMDX
TransMedics Group
4.2412 of 5 stars
$64.71
-6.0%
$122.70
+89.6%
-27.3%$2.17B$401.09M68.84210News Coverage
CNMD
CONMED
4.7698 of 5 stars
$69.87
+1.5%
$79.80
+14.2%
-38.1%$2.16B$1.29B16.604,100
LMAT
LeMaitre Vascular
2.8735 of 5 stars
$94.11
+0.6%
$94.57
+0.5%
+74.1%$2.12B$213.03M51.43490Short Interest ↑
News Coverage

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners